Study summary

The study is intended to test efficacy, safety and tolerability of two doses of Mirabegron against placebo and compare the efficacy and safety with active comparator in patients with symptoms of overactive bladder.

Additional Study Details

Phase
3
Product
N/A
Product
Mirabegron
Tolterodine
Placebo to Mirabegron
Placebo to Tolterodine
Type
Interventional
Masking
Double (Participant, Investigator)
Enrollment number
2336
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients with Symptoms of Overactive Bladder? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Lutherstadt Eisleben, Germany, 06295
    Completed
    Berlin, Germany, 13347
    Completed
    Bilbao, Spain, 48013
    Completed
    Trencin, Slovakia, 91101
    Completed
    Madrid, Spain, 28046
    Completed
    Melnik, Czech Republic, 27601
    Completed
    Northwood, United Kingdom, HA6 2RN
    Completed
    Oranienburg, Germany, 16151
    Completed
    Barcelona, Spain, 08020
    Completed
    Plzen, Czech Republic, 30599
    Completed
    Minsk, Belarus, 223041
    Completed
    Florence, Italy, 59129
    Completed
    Varese, Italy, 21100
    Completed
    Milan, Italy, 20142
    Completed
    Uetersen, Germany, 25436
    Completed
    Tonsberg, Norway, 3103
    Completed
    Reading, United Kingdom, RG2 7AG
    Completed
    Naples, Italy, 80131
    Completed
    Zilina, Slovakia, 01207
    Completed
    Leper, Belgium, 8900
    Completed
    Timisoara, Romania
    Completed
    Leipzig, Germany, 04105
    Completed
    London, United Kingdom, SE5 9RS
    Completed
    Nantes, France, 45035
    Completed
    Tomar, Portugal, 2304-909
    Completed
    Debrecen, Hungary, 4043
    Completed
    Liverpool, United Kingdom, L22 OLG
    Completed
    Orleans Cedex 2, France, 45067
    Completed
    Vilnius, Lithuania
    Completed
    Patras, Greece
    Completed
    Marseille, France, 13285
    Completed
    Poprad, Slovakia, 05801
    Completed
    Palma de Mallorca, Spain, 07014
    Completed
    Bergen, Norway, 5021
    Completed
    Sangerhausen, Germany, 06526
    Completed
    Muenchen-Bogenhausen, Germany, 81925
    Completed
    Liege, Belgium, 4000
    Completed
    Kiev, Ukraine, 04053
    Completed
    Modena, Italy, 41100
    Completed
    Croydon, United Kingdom, CR7 7YE
    Completed
    Frauenfeld, Switzerland, 8501
    Completed
    Liepaja, Latvia
    Completed
    Miranda de Ebro, Spain, 09200
    Completed
    Birmingham, United Kingdom, B15 2TG
    Completed
    Lodz, Poland, 93-338
    Completed
    Madrid, Spain, 28016
    Completed
    Koblenz, Germany, 56068
    Completed
    Trier, Germany, 54290
    Completed
    Lublin, Poland, 20-954
    Completed
    Paris, France, 75020
    Completed
    Florence, Italy, 50139
    Completed
    Marseille Cedex 9, France, 13274
    Completed
    Stockholm, Sweden, 17176
    Completed
    Olomouc, Czech Republic, 77200
    Completed
    Nyiregyhaza, Hungary, 4400
    Completed
    Dublin, Ireland
    Completed
    Colmar, France, 68024
    Completed
    Warsaw, Poland, 02-507
    Completed
    Leiden, Netherlands, 2334 CK
    Completed
    Aarhus, Denmark, 8200
    Completed
    Chorzow, Poland, 41-500
    Completed
    Milan, Italy, 20153
    Completed
    Amsterdam, Netherlands, 1105 AZ
    Completed
    St. Petersburg, Russian Federation, 198013
    Completed
    Turku, Finland, 20100
    Completed
    Nijmegen, Netherlands, 6532 SZ
    Completed
    Paarl, South Africa
    Completed
    Budapest, Hungary, 1047
    Completed
    Reading, United Kingdom, RG1 5AN
    Completed
    Neustadt i. Sachsen, Germany, 01844
    Completed
    Szekszard, Hungary, 7100
    Completed
    Hamar, Norway, 2317
    Completed
    Hagenow, Germany, 19230
    Completed
    Sofia, Bulgaria
    Completed
    Warsaw, Poland, 02-005
    Completed
    Steti, Czech Republic, 41108
    Completed
    Halle/Saale, Germany, 06132
    Completed
    Reykjavik, Iceland, 101
    Completed
    Aichach, Germany, 86551
    Completed
    Warsaw, Poland, 00-846
    Completed
    Sopron, Hungary
    Completed
    Valencia, Spain, 46010
    Completed
    Tralee, Ireland
    Completed
    Nikaias-Piraeus, Greece
    Completed
    Duisburg, Germany, 47051
    Completed
    Riga, Latvia
    Completed
    Prague, Czech Republic, 14056
    Completed
    Bautzen, Germany, 02625
    Completed
    London, United Kingdom, W2 2YP
    Completed
    Boras, Sweden, 50182
    Completed
    Bucharest, Romania
    Completed
    Moscow, Russian Federation, 115516
    Completed
    Perugia, Italy, 06122
    Completed
    Sheffield, United Kingdom, S10 2JF
    Completed
    Lasi, Romania
    Completed
    Graz, Austria, 8036
    Completed
    Ostrava-Poruba, Czech Republic, 70853
    Completed
    Nimes Cedex 9, France, 30029
    Completed
    Toledo, Spain, 45071
    Completed
    Minsk, Belarus, 220036
    Completed
    Viana do Castelo, Portugal, 4900-858
    Completed
    Aalborg, Denmark, 9100
    Completed
    Athens, Greece
    Completed
    Umea, Sweden, 90185
    Completed
    Moscow, Russian Federation, 123836
    Completed
    Tilburg, Netherlands, 5022 GC
    Completed
    Linz, Austria, 4020
    Completed
    Oulu, Finland, 90220
    Completed
    Luzern, Switzerland, 6000
    Completed
    Toulouse Cedex 9, France, 31059
    Completed
    Bad Ems, Germany, 56130
    Completed
    Brussels, Belgium, 1070
    Completed
    Tampere, Finland, 33521
    Completed
    Roskilde, Denmark
    Completed
    Lyttelton, South Africa
    Completed
    Maastricht, Netherlands, 6229 HX
    Completed
    Swansea, United Kingdom, SA6 6NL
    Completed
    Usti nad Labem, Czech Republic, 40001
    Completed
    Sint Truiden, Belgium, 3800
    Completed
    Chorley, United Kingdom, PR7 7NA
    Completed
    Varna, Bulgaria
    Completed
    Hamburg, Germany, 20253
    Completed
    Antwerp, Belgium, 2020
    Completed
    Papa, Hungary
    Completed
    Porto, Portugal, 4099-005
    Completed
    Randwick, Australia
    Completed
    Genoa, Italy, 16128
    Completed
    Mullingar, Ireland
    Completed
    Getafe, Spain, 28905
    Completed
    Sneek, Netherlands, 8600 BA
    Completed
    Radebeul, Germany, 01445
    Completed
    Uppsala, Sweden, 75185
    Completed
    Newcastle Upon Tyne, United Kingdom, NE7 7DN
    Completed
    Amadora, Portugal, 2700
    Completed
    Innsbruck, Austria, 6020
    Completed
    Catanzaro, Italy, 88100
    Completed
    Brno, Czech Republic, 60200
    Completed
    Auchenflower, Australia
    Completed
    Minsk, Belarus, 220119
    Completed
    Stockholm, Sweden, 14186
    Completed
    Drammen, Norway, 3016
    Completed
    Martin, Slovakia, 03659
    Completed
    Oslo, Norway, 0257
    Completed
    Apeldoorn, Netherlands
    Completed
    Mulhouse, France, 68070
    Completed
    Gent, Belgium, 9000
    Completed
    Pietermaritzburg, South Africa
    Completed
    Ganderkesee, Germany, 27777
    Completed
    Clayton, Australia
    Completed
    Szekesfehervar, Hungary, 8000
    Completed
    Moscow, Russian Federation, 105425
    Completed
    Antwerp, Belgium, 2030
    Completed
    Lodz, Poland, 93-513
    Completed
    Saint Priest en Jarez, France, 42055
    Completed
    Orebro, Sweden, 70185
    Completed
    Veszprem, Hungary, 8200
    Completed
    Kogarah, Australia
    Completed
    Enschede, Netherlands, 7511 JX
    Completed
    Wroclaw, Poland, 50-556
    Completed
    Skovde, Sweden, 54130
    Completed
    Bordeaux, France, 33076
    Completed
    Kaunas, Lithuania
    Completed
    Edegem, Belgium, 2650
    Completed
    Szeged, Hungary, 6725
    Completed
    Oradea, Romania
    Completed
    Helsinki, Finland, 00029
    Completed
    Winterswijk, Netherlands, 7101 BN
    Completed
    Strasbourg, France, 67000
    Completed
    Helsingborg, Sweden, 25187
    Completed
    Eger, Hungary, 3300
    Completed
    Latina, Italy, 04100
    Completed
    Apeldoorn, Netherlands, 7334 DZ
    Completed
    Sevilla, Spain, 41013
    Completed
    Madrid, Spain
    Completed
    Fuenlabrada, Spain, 28942
    Completed
    Brussels, Belgium, 1090
    Completed
    Bari, Italy, 70124
    Completed
    Skalica, Slovakia, 90982
    Completed
    Pleven, Bulgaria
    Completed
    Glostrup, Denmark, 2600
    Completed
    Moscow, Russian Federation, 119435
    Completed
    Esplugues de Llobregat-Barcelo, Spain, 08950
    Completed
    Tatabanya, Hungary, 2800
    Completed
    Moscow, Russian Federation, 111020
    Completed
    Villareal, Spain, 12540
    Completed
    Rouen, France, 76031
    Completed
    Treviglio, Italy, 24047
    Completed
    Moscow, Russian Federation, 101000
    Completed
    Leuven, Belgium, 3000
    Completed
    Hatfield, South Africa
    Completed
    Manchester, United Kingdom, M15 6SX
    Completed
    Frankfurt, Germany, 65933
    Completed
    Cork, Ireland
    Completed
    Mataro, Spain, 8304
    Completed
    Bloemfontein, South Africa
    Completed
    Kortrijk, Belgium, 8500
    Completed
    Moscow, Russian Federation, 111123
    Completed
    Woolloongabba, Australia
    Completed
    Henningsdorf, Germany, 16761
    Completed
    Bialystok, Poland, 15-278
    Completed
    Thessaloniki, Greece
    Completed
    Teramo, Italy, 64100
    Completed
    Paris-Cedex 12, France, 75571
    Completed
    Hettstedt, Germany, 06333
    Completed
    Dublin 9, Ireland
    Completed
    Magenta, Italy, 20013
    Completed
    Eindhoven, Netherlands, 5623 EJ

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?